Guangxi Wuzhou Zhongheng Group (600252.SH) stated on the investor interaction platform on October 31 that the company is strengthening cooperation with large domestic pharmaceutical commerce enterprises, carrying out distribution and promotion of core products such as Zhonghua Dit da Wan for major domestic chain enterprises and terminal pharmacies, and generic drug series products have certain sales in mainstream chain pharmacies in China.
中恒集团(600252.SH):普药系列产品在国内主流连锁药店均有一定的销售
Guangxi Wuzhou Zhongheng Group (600252.SH): The general medicine series products have a certain level of sales in mainstream domestic chain pharmacies.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.